The choice of approaches to the treatment of patients with open arterial canal



Cite item

Full Text

Abstract

The aim of the study is to assess immediate results of surgical and transcatheter treatment of patients with patent ductus arteriosus and to detect risk factors of development residual shunt after PDA occlusion. 253 consecutive patients were included. Surgery group contained 108 patients and transcatheter group contained 145 patients. There were no death cases in both groups. Residual shunts developed in 19 patients (15.83%) in surgery group and in 2 patients (1.37%) in transcatheter group (р<0,0001). Patients with residual shunts in comparison with those with no residual shunts have significantly larger diameter of pulmonary end of the PDA (р<0,0001). Transcatheter occlusion of patent ductus arteriosus can be safely and effectively achieved in patients with ductus diameters up to 3.7 mm.

Full Text

Выбор подходов к лечению больных с открытым артериальным протоком
×

About the authors

M S Khokhlunov

References

  1. Gross RE, Hubbard JP: Surgical ligation of a PDA; report of first successful case, JAMA 112:729, 1939.
  2. Porstmann W, Wierny L, Warnke H: Closure of the persistent ductus arteriosus without thoracotomy, Ger Med Mon 12:259, 1967.
  3. Mavrodis C, Backer CL, Gevitz M. Forty-six years of patent ductus arteriosus division at Children`s Memorialo Hospital of Chicago. Ann Surg 1994; 220:402.
  4. Musewe NN, Benson LN, Smallhorn JF, et al: Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis, Circulation 80:1706, 1989.
  5. Raaijmaakers B, Nijveld A, van Oort A, et al: Difficulties generated by the small, persistently patent, arterial duct, Cardiol Young 9:392, 1999.
  6. Gray DT, Fyler DC, Walker AM, et al: Clinical outcomes and costs of transcatheter as compared with surgical closure of PDA. The PDA Closure Comparative Study Group, N Engl J Med 329:1517, 1993.
  7. Sorensen KE, Kristensen B, Hansen OK: Frequency of occurrence of residual ductal flow after surgical ligation by color-flow map- ping, Am J Cardiol 67:653, 1991.
  8. Lloyd TR. PDA coil registry. Accessed August 3, 2003. Available at: www.med.umich.edu/pdc/pdacoil/data.htm.
  9. Prieto LR, DeCamillo DM, Konrad DJ, et al: Comparison of cost and clinical outcome between transcatheter coil occlusion and surgical closure of isolated PDA, Pediatrics 101:1020, 1998.
  10. Goyal VS, Fulwani MC, Ramakantan R, et al: Follow-up after coil closure of PDA, Am J Cardiol 83:463, 1999.
  11. Radtke WAK: Comparison of efficacy and safety of the Rashkind occluder vs. Gianturco coils for PDA occlusion. In Proceedings of the Second World Congress of Pediatric Cardiology and Cardiac Surgery, Mt Kisco, NY, 1998, Futura Publishing.
  12. Singh TP, Morrow WR, Walters HL, et al: Coil occlusion versus conventional surgical closure of PDA, Am J Cardiol 79:1283, 1997.
  13. Shim D, Fedderly RT, Beekman RH III, et al: Follow-up of coil occlusion of PDA, J Am Coll Cardiol 28:207, 1996.
  14. Uzun O, Dickinson D, Parsons J, et al: Residual and recurrent shunts after implantation of Cook detachable duct occlusion coils, Heart 79:220, 1998.
  15. Musewe NN, Benson LN, Smallhorn JF, et al: Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis, Circulation 80:1706, 1989.
  16. Raaijmaakers B, Nijveld A, van Oort A, et al: Difficulties generated by the small, persistently patent, arterial duct, Cardiol Young 9:392, 1999.
  17. Gray DT, Fyler DC, Walker AM, et al: Clinical outcomes and costs of transcatheter as compared with surgical closure of PDA. The PDA Closure Comparative Study Group, N Engl J Med 329:1517, 1993.
  18. Sorensen KE, Kristensen B, Hansen OK: Frequency of occurrence of residual ductal flow after surgical ligation by color-flow map- ping, Am J Cardiol 67:653, 1991.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Khokhlunov M.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies